Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Hemispherx Biopharma Inc. (HEB)

   0 (0%)
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M
Hemispherx Biopharma Inc is a specialty pharmaceutical company. It is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.063 - 2.071 2.071 - 2.079
Low: 1.88 - 1.889 1.889 - 1.897
Close: 1.946 - 1.96 1.96 - 1.973

Technical analysis

as of: 2019-10-25 4:34:22 PM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 2.48     One year: 2.92
Support: Support1: 1.51    Support2: 1.26
Resistance: Resistance1: 2.12    Resistance2: 2.50
Pivot: 1.88
Moving Average: MA(5): 1.87     MA(20): 1.89
MA(100): 4.33     MA(250): 7.17
MACD: MACD(12,26): -0.24     Signal(9): -0.31
Stochastic oscillator: %K(14,3): 65.41     %D(3): 59.39
RSI: RSI(14): 37.66
52-week: High: 14.96  Low: 1.51  Change(%): -82.9
Average Vol(K): 3-Month: 13858  10-Days: 4042

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
HEB has closed below upper band by 7.5%. Bollinger Bands are 91.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to HEB's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 23 Aug 2019
Hemispherx Biopharma, Inc. Changes Name to AIM ImmunoTech Inc. Reflecting Ampligen's® Immuno Modulation Progress in Ongoing Oncology Clinical Trials and ME/CFS - GlobeNewswire

Fri, 02 Aug 2019
Hemispherx Biopharma corrects reports that mistakenly inflated the value of its private placement - Proactive Investors USA & Canada

Tue, 25 Jun 2019
Hemispherx Biopharma Inc (HEB) Exec. Vice Chairman/CEO/Pres. Thomas K. ... - Yahoo Finance

Fri, 31 May 2019
Hemispherx Biopharma Stockholders Approve Reverse Stock Split - GlobeNewswire

Tue, 11 Jun 2019
Hemispherx Biopharma shares soar as reverse split takes effect - Proactive Investors USA & Canada

Tue, 16 Jul 2019
Who Has Been Buying Hemispherx Biopharma, Inc. (NYSEMKT:HEB) Shares? - Simply Wall St

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  NA
Industry:  NA
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS Est This Year
EPS Est Next Year -0.030
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.) -2.056
Sales Per Share
EBITDA (p.s.) -43.859
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 2143132.25
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.